MCID: FGS003
MIFTS: 13

Fg Syndrome 3

Categories: Rare diseases

Aliases & Classifications for Fg Syndrome 3

MalaCards integrated aliases for Fg Syndrome 3:

Name: Fg Syndrome 3 54 50 13 69
Fgs3 50

Classifications:



External Ids:

OMIM 54 300406

Summaries for Fg Syndrome 3

MalaCards based summary : Fg Syndrome 3, is also known as fgs3. An important gene associated with Fg Syndrome 3 is FGS3 (FG Syndrome 3). The drugs Enalapril and Enalaprilat have been mentioned in the context of this disorder. Affiliated tissues include ovary.

Description from OMIM: 300406

Related Diseases for Fg Syndrome 3

Symptoms & Phenotypes for Fg Syndrome 3

Clinical features from OMIM:

300406

Drugs & Therapeutics for Fg Syndrome 3

Drugs for Fg Syndrome 3 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 46)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
2
Enalaprilat Approved Phase 4 76420-72-9 6917719
3
Losartan Approved Phase 4 114798-26-4 3961
4
Angiotensin II Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
5 Angiotensin II Type 1 Receptor Blockers Phase 4
6 Angiotensin Receptor Antagonists Phase 4
7 Angiotensin-Converting Enzyme Inhibitors Phase 4
8 Angiotensinogen Phase 4
9 Anti-Arrhythmia Agents Phase 4
10 Antihypertensive Agents Phase 4
11 HIV Protease Inhibitors Phase 4
12
protease inhibitors Phase 4
13
Ticagrelor Approved Phase 3 274693-27-5 9871419
14
Ticlopidine Approved Phase 3 55142-85-3 5472
15
Darbepoetin alfa Approved, Investigational Phase 3 11096-26-7, 209810-58-2
16
Clopidogrel Approved, Nutraceutical Phase 3 120202-66-6, 113665-84-2 60606
17 Cytochrome P-450 Enzyme Inhibitors Phase 3
18 Fibrinolytic Agents Phase 3
19 Neurotransmitter Agents Phase 3
20 Platelet Aggregation Inhibitors Phase 3
21 Purinergic P2 Receptor Antagonists Phase 3
22 Purinergic P2Y Receptor Antagonists Phase 3
23 Hematinics Phase 3
24
Cyproterone Acetate Approved, Investigational 427-51-0
25
Estradiol Approved, Investigational, Vet_approved 50-28-2 5757
26
Metformin Approved 657-24-9 14219 4091
27 Neuroserpin
28 Androgen Antagonists
29 Androgens
30 Contraceptive Agents
31 Contraceptive Agents, Male
32 Contraceptives, Oral
33 Contraceptives, Oral, Combined
34
Cyproterone 2098-66-0 5284537
35 Estradiol 17 beta-cypionate
36 Estradiol 3-benzoate
37 Estradiol valerate 979-32-8
38 Estrogens
39 Hormone Antagonists
40 Hormones
41 Hormones, Hormone Substitutes, and Hormone Antagonists
42 Hypoglycemic Agents
43 insulin
44 Insulin, Globin Zinc
45 Polyestradiol phosphate
46 Astragalus Nutraceutical

Interventional clinical trials:

(show all 11)

id Name Status NCT ID Phase Drugs
1 Prevention of Diabetes and Hypertension Terminated NCT00456963 Phase 4 enalapril tablets;placebo tablets;Losartan Tablets
2 Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome Completed NCT02342184 Phase 3 GB-0998
3 Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome Completed NCT02221271 Phase 3 NPB-01
4 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome Completed NCT00391872 Phase 3 Ticagrelor;Clopidogrel
5 Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden Recruiting NCT03263091 Phase 3 FG-4592;Placebo
6 Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Active, not recruiting NCT01362140 Phase 3 Darbepoetin alfa;Placebo
7 Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Lower Risk MDS Not yet recruiting NCT03303066 Phase 2, Phase 3 FG-4592;Placebo
8 JET-GBS - Japanese Eculizumab Trial for GBS Completed NCT02493725 Phase 2 Eculizumab;Placebo
9 Genetic Disease Gene Identification Unknown status NCT00916903
10 OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women Recruiting NCT02744131 Oral contraceptive pill combination of ethyl estradiol and Cyproterone acetate;Metformin 1500mgs per day
11 Electroacupuncture on Hormonal and Glycometabolic Profiles in Women With Polycystic Ovary Syndrome: Study Protocol Not yet recruiting NCT02653911

Search NIH Clinical Center for Fg Syndrome 3

Genetic Tests for Fg Syndrome 3

Anatomical Context for Fg Syndrome 3

MalaCards organs/tissues related to Fg Syndrome 3:

39
Ovary

Publications for Fg Syndrome 3

Variations for Fg Syndrome 3

Expression for Fg Syndrome 3

Search GEO for disease gene expression data for Fg Syndrome 3.

Pathways for Fg Syndrome 3

GO Terms for Fg Syndrome 3

Sources for Fg Syndrome 3

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....